Prof Ymkje Stienstra

Internist/infectious Diseases Specialist and Clinical Epidemiologist
Institution: University of Groningen / University Medical Center Groningen
Current Insitution Location: Netherlands

Email: y.stienstra@umcg.nl
Phone Number: +31-50-3616161
Website: Go to website

Hanzeplein 1, 9700 RB Groningen, the Netherlands

Migration Health Research Area/Expertise:
Evaluated differences in vaccination strategies in Europe (Eurosurveillance). Evaluated effect on complications of scabies after ivermectin given upon arrival of refugees from high-risk group. Qualitative work on migrants’ ideas and wishes in vaccination and screening. Chairs the European study group on infections in travelers and migrants (ESGITM), part of ESCMID (European society clinical microbiology and infectious diseases). Coordinator of Marie Curie H2020 grant on infectious diseases promoting European research mobility.

Research Focus/Expertise on Relevant Migrant Categories:
International/Cross-Border Migration
Asylum seekers (Children, Adolescents, Adults, Elderly)
International students (Children, Adolescents, Adults, Elderly)
Refugees (Children, Adolescents, Adults, Elderly)

General Research Focus/Expertise: 
Infectious diseases
Internal medicine
Public Health

Relevant Publications

Title Author Year Published Link to Publication
National approaches to the vaccination of recently arrived migrants in Europe: A comparative policy analysis across 32 European countries Ravensbergen SJ, Nellums LB, Hargreaves S, Stienstra Y, Friedland JS 2018
Divergent approaches in the vaccination of recently arrived migrants to Europe: a survey of national experts from 32 countries, 2017 Hargreaves S, Nellums LB, Ravensbergen SJ, Friedland JS, Stienstra Y 2018
Efficacy of ivermectin mass-drug administration to control scabies in asylum seekers in the Netherlands: A retrospective cohort study between January 2014 - March 2016 Beeres DT, Ravensbergen SJ, Heidema A, Cornish D, Vonk M, Wijnholds LD, Hendriks JJH, Kleinnijenhuis J, Omansen TF, Stienstra Y 2018
Screening for infectious diseases of asylum seekers upon arrival: the necessity of the moral principle of reciprocity Beeres DT, Cornish D, Vonk M, Ravensbergen SJ, Maeckelberghe ELM, Boele Van Hensbroek P, Stienstra Y 2018
Case Report: Carbapenemase-Producing Enterobacteriaceae in an Asylum Seeker with Multidrug-Resistant Tuberculosis Ravensbergen SJ, Louka C, Lokate M, Bathoorn E, Pournaras S, van der Werf TS, de Lange WCM, Stienstra Y, Akkerman OW 2018
High prevalence of MRSA and ESBL among asylum seekers in the Netherlands Ravensbergen SJ, Berends M, Stienstra Y, Ott A 2017
High Prevalence of Infectious Diseases and Drug-Resistant Microorganisms in Asylum Seekers Admitted to Hospital; No Carbapenemase Producing Enterobacteriaceae until September 2015 Ravensbergen SJ, Lokate M, Cornish D, Kloeze E, Ott A, Friedrich AW, van Hest R, Akkerman OW, de Lange WC, van der Werf TS, Bathoorn E, Stienstra Y 2016
Louse-borne relapsing fever (Borrelia recurrentis) in asylum seekers from Eritrea, the Netherlands, July 2015 Wilting KR, Stienstra Y, Sinha B, Braks M, Cornish D, Grundmann H 2015